ABUS Net Income Growth
Arbutus Biopharma Corp · Net Income Growth
ABUS Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported382.12%period ending
ABUS TTM Net Income YoY % (-289.49% → 382.12%)
Year-over-year change
High-resolution chart · PNG
ABUS net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 382.1168% | |
| 309.8967% | |
| 52.0867% | |
| 44.8801% | |
| 29.6224% | |
| -2.9388% | |
| 4.0206% | |
| -1.6311% | |
| -5.6971% | |
| -6.2188% | |
| -4.8851% | |
| -9.6216% | |
| -3.5436% | |
| 7.4057% | |
| 8.9066% | |
| 4.3394% | |
| 1.5776% | |
| -14.1342% | |
| -19.6125% | |
| -0.8563% | |
| 47.0301% | |
| 54.0888% | |
| 58.5326% | |
| 51.5626% | |
| -51.3137% | |
| -129.5299% | |
| -169.4059% | |
| -97.102% | |
| -44.3178% | |
| 24.4343% | |
| 32.4038% | |
| 72.0253% | |
| 77.5162% | |
| 78.4928% | |
| 78.0268% | |
| -56.4882% | |
| -52.7715% | |
| -495.0738% | |
| -528.3864% | |
| -175.2027% | |
| -332.3468% | |
| -97.9782% | |
| -57.4143% | |
| -75.8244% | |
| -27.8846% | |
| -11.5284% | |
| -176.6039% | |
| -229.8286% | |
| -210.1177% | |
| -196.0946% | |
| -146.7176% | |
| 359.4228% | |
| 452.114% | |
| 401.6845% | |
| 395.2945% | |
| -8.0023% | |
| 22.811% | |
| 9.5741% | |
| 17.7837% | |
| 28.4609% | |
| 20.0051% | |
| 2.746% | |
| -39.7097% | |
| -86.3452% | |
| -31.8888% | |
| 12.0671% | |
| 25.6225% | |
| 30.7657% | |
| -212.1083% | |
| -289.4921% |